SELLAS Life Sciences (SLS) Preferred Dividend Payments (2018)
SELLAS Life Sciences' (SLS) quarterly Preferred Dividend Payments came in at $2.5 million in Q2 2018, up 25.41% on a QoQ basis from $2.0 million in Q1 2018.
SELLAS Life Sciences (SLS) Preferred Dividend Payments (2018) Analysis & Trends
SELLAS Life Sciences (SLS) has 1 years of Preferred Dividend Payments data on file, last reported at $2.5 million in Q2 2018.
- On a quarterly basis, Preferred Dividend Payments changed N/A year-over-year to $2.5 million in Q2 2018; TTM through Mar 2019 was $2.5 million, a 25.41% increase from a year earlier, with the FY2018 full-year figure at $4.4 million, changed N/A from the prior year.
- Preferred Dividend Payments for Q2 2018 stood at $2.5 million, up from $2.0 million in the prior quarter.
- Over the last five years, Preferred Dividend Payments for SLS reached as high as $2.5 million in Q2 2018 and fell as low as $2.0 million in Q1 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | SELLAS Life Sciences | 1.96 Bn | 1.96 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | 2.47 Mn |
| Mar 31, 2018 | 1.97 Mn |